Improving Lives by Supporting
Biotherapeutic Innovations

Texcell is a contract research organization that specializes in virus testings, viral clearance and safety, immunoprofiling, R&D and GMP cell banking, for your R&D, GClP, GLP and GMP applications.

Company News

Nov

25

Recruiting Study Director Viral Safety

To meet its growth, Texcell is recruiting for its Paris Office a Study Director Viral Safety.

Click read more, download the offer and join the team!

Nov

25

The China National Medical Products Administration has approved BAT1406. 

Congratulations to Bio-Thera as the first adalimumab biosimilar has been approved by the NMPA in China!
Texcell is proud to have contributed to this success with the viral safety performed in France.

Company Events

Nov

25

Cell Therapy Manufacturing & Gene Therapy Congress

Texcell will exhibit there from 4 & 5 December 2019, in Amsterdam, The Netherlands.
Meet Texcell's experts in GMP Cell banking and Viral testing at booth #21.

Oct

18

Bio-Europe

Texcell and Vivo Science, a Texcell compary, share a booth at Bio Europe in Hamburg.
Thank you to all visitors who stopped by and see you next spring !